home : about us : ahead of print : current issue : archives search instructions : subscriptionLogin 
Users online: 15322      Small font sizeDefault font sizeIncrease font size Print this page Email this page
Year : 2008  |  Volume : 3  |  Issue : 1  |  Page : 35-40

Management in refractory epilepsy: Beyond epilepsy surgery...

Consultant Neurologist, P. D. Hinduja National Hospital, Veer Savarkar Marg, Mahim, Mumbai - 40016, India

Correspondence Address:
Roop Gursahani
2101, Hinduja Clinic, P. D. Hinduja Hospital, Veer Savarkar Marg, Mahim, Mumbai - 400016
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/1817-1745.40588

Rights and Permissions

Although definititions of refractory epilepsy vary, about 40% of prevalent cases of epilepsy are not controlled by anti-epileptic drugs. A substantial proportion of this population requires palliative therapy since only a minority are candidates for epilepsy surgery. Drug therapy can be optimised after accurate classification of the epilepsy. Monotherapy is often as effective as polytherapy with fewer adverse effects. Depression and CNS adverse effects significantly impact quality of life and must be systematically screened for and treated. The ketogenic diet and vagal nerve stimulation provide substantial seizure control in a significant number of cases and may be used synergistically. Deep brain stimulation is another promising modality.


Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded529    
    Comments [Add]    
    Cited by others 2    

Recommend this journal